Cannabis in Hawaii has developed over time, shaped by local traditions, shifting laws, and a culture closely tied to the land. Long before modern legalization frameworks, pakalōlō was already part of island life—referenced in Hawaiian-language newspapers in the 1800s and used in traditional healing practices alongside other plant-based remedies. Its role shifted with changing political control, moving from a locally integrated plant to one shaped by U.S. prohibition.
In recent years, a new layer has emerged alongside the state’s tightly regulated medical system. Companies like Rare Cannabinoid Company are helping drive a more functional approach built around specific effects like energy, mood, and sleep, rather than a one-dimensional experience. It’s a shift that fits naturally into the rhythm of the islands.
To understand how Hawaii got here, you have to go back.
Pakalōlō: Early Origins and Cultural Roots
Cannabis—known locally as pakalōlō, meaning “numbing tobacco”—has been part of Hawaii’s cultural fabric for nearly two centuries, with documented use dating back to at least 1842. How it first arrived is still debated. Some historians point to a botanist traveling with Captain Cook. Others trace it to Mexican paniolos (vaqueros / cowboys). Either way, cannabis became integrated into island life early on.
It wasn’t fringe. It was practical. In the 1800s, cannabis was used in traditional healing practices (lāʻau lapaʻau), and advertisements for medicinal cannabis appeared in Hawaiian newspapers decades before U.S. prohibition. Families cultivated localized strains adapted to Hawaii’s unique microclimates, aided by the traditional ahupuaʻa land system that stretched from mountain to sea.
Over time, those genetics evolved into what the world now recognizes as classic Hawaiian strains:
- Maui Wowie
- Kona Gold
- Kauaʻi Electric
- Molokaʻi Purpz
These weren’t just products—they were tied to place, climate, and lineage.
Criminalization and Green Harvest
Cannabis prohibition in Hawaii followed U.S. annexation and federal policy shifts in the early 20th century. By 1927, cannabis was officially criminalized, with enforcement often disproportionately targeting plantation labor communities.
Decades later, enforcement intensified through Operation Green Harvest, a federal-state campaign that ran from the late 1970s through the 1990s. Helicopters, aerial surveillance, and coordinated raids wiped out large portions of outdoor cultivation—especially on the Big Island of Hawai’i.
Beyond enforcement, the impact was cultural. Local growers went underground. Traditional genetics were lost. And in some communities, the crackdown coincided with the rise of harder substances, including methamphetamine.
Still, cannabis never left Hawaii. It adapted.
Legalization—But Not Like the Mainland
Hawaii took a different path than most states. In 2000, it became the first U.S. state to legalize medical cannabis through legislation rather than a ballot initiative. That law allowed patients to grow their own cannabis or appoint a caregiver—but didn’t create dispensaries or a retail system.
That came later.
- 2015: The state established a regulated dispensary program
- 2017: The first legal dispensary sale took place on Maui
- Today: Hawaii operates under a medical-only system
Access requires a 329 medical card, issued by the Department of Health. Tourists can participate, but only by registering an out-of-state medical card. Recreational cannabis remains illegal as of 2026. Possession of small amounts (three grams or less) is decriminalized, typically resulting in a fine rather than jail time.
What makes Hawaii especially unique is how dispensaries operate: they must grow, process, and sell their own cannabis. The state allows only a small number of licensed operators—just eight companies across all islands—each permitted a limited number of retail locations.
No outside brands. No imports. Everything is local by design.
A Parallel Market: Hemp and Accessibility
While the cannabis medical system is tightly controlled, hemp-derived cannabinoids follow a separate regulatory framework—allowing federally compliant products (containing less than 0.3% THC) to be sold outside dispensaries.
This is where companies like Rare Cannabinoid Company operate.
Because these products are derived from hemp and formulated within federal guidelines, they can be sold outside the state’s dispensary system—both online and in retail settings. That creates a different kind of access for residents and visitors alike, without relying on the medical program. Rare Cannabinoid Company distributes its edibles, tinctures, and topicals in hundreds of locations across Hawaii and the U.S. Mainland, including health food stores, clinics, and hotel spas, and is now Hawaii’s largest exporter of Hawaiian hemp products.
Rare Cannabinoid Company is also changing how cannabis/hemp is used. The plant contains more than 100 cannabinoids, each with distinct effects. Instead of relying on one dominant compound, the Honolulu-based brand’s formulations isolate and combine specific cannabinoids to target particular outcomes—closer to an apothecary model than traditional use.
Products are built around defined experiences:
- THCV for energy, focus, and functional support
- CBC for mood, often paired with THC and CBD in products like THC + CBC Mood Gummies
- CBN for nighttime routines, often paired with THC in products like THC + CBN Gummies
- CBG for recovery-oriented and topical wellness routines
- CBDV for sociability and a more balanced, even mood
In a place like Hawaii, those use cases fit naturally. Early-morning surf sessions. Long hikes. Evenings out in Honolulu. Visitors in Waikiki looking for an alternative to alcohol. Cannabis isn’t separate from these experiences—it’s integrated into them.
Cannabis and Daily Life in Hawaii
In Hawaii, cannabis is still part of the background. You’ll smell it at the beach. At a backyard BBQ. After a surf session when the boards are stacked and the sun is dropping. It’s present, but not always the focus.
That’s part of what distinguishes the culture here. It’s less about excess, more about context. The shift toward functional cannabinoids builds on that. A low-dose product before a hike. A mood-focused edible instead of drinks. A more controlled experience that aligns with the pace of island life.
The Direction of the Islands
Hawaii remains one of the best places in the world to grow cannabis and hemp. The climate allows for year-round cultivation. Volcanic soil adds mineral richness. Microclimates across the islands create natural variation.
Historically, that led to isolated landrace strains. Today, it supports both traditional cultivation and modern cannabinoid production. That combination—environment plus innovation—is what’s driving the current evolution.
Hawaii’s cannabis industry is still in transition. The medical system remains the primary legal pathway, and broader legalization efforts have yet to move forward. At the same time, research into cannabinoids is expanding, and interest is shifting toward more targeted, functional use.
That combination—limited access on one side, growing demand and innovation on the other—continues to shape how cannabis develops in the islands.
Hawaii’s cannabis culture has always been shaped by its environment—isolated, self-contained, and local by necessity. That hasn’t changed, even as the products and conversations around cannabis have. What has changed is the level of precision. Instead of a single general experience, there’s a growing focus on specific effects—energy, mood, rest—and how they fit into everyday life.
At the same time, the system around cannabis remains constrained, and the gap between demand, access, and regulation is still being worked out.
Where Hawaii goes next will likely be less about rapid expansion and more about how those pieces come into alignment.
Images courtesy of Rare Cannabinoid Co.
Sponsored Content Disclaimer: This article was published as part of a paid commercial arrangement with Rare Cannabinoid Company. It is not independent editorial content. Historical references, cannabinoid discussions, product descriptions, and consumer-use examples reflect a combination of historical reporting and the company’s perspective unless otherwise noted and have not been independently verified by High Times.
